We are live on
!
Find out more
PCG
PFC Capital Group Portfolio holdings
AUM
$260M
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+12.06%
1 Year Est. Return
+31.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$216M
AUM Growth
+$17.7M
(+8.9%)
Cap. Flow
-$1.13M
Cap. Flow
% of AUM
-0.52%
Top 10 Holdings %
Top 10 Hldgs %
54.95%
Holding
88
New
2
Increased
13
Reduced
58
Closed
6
Avg Time Held
4.6
quarters
Top 10 Avg Time Held
5.1
quarters
Top 20 Avg Time Held
4.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.17M |
| 2 |
Vanguard Total Bond Market
BND
|
+$1.49M |
| 3 |
Avantis US Large Cap Value ETF
AVLV
|
+$1.19M |
| 4 |
Avantis Emerging Markets Value ETF
AVES
|
+$1.19M |
| 5 |
Avantis US Small Cap Value ETF
AVUV
|
+$1.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.34M |
| 2 |
Amazon
AMZN
|
+$839K |
| 3 |
Apple
AAPL
|
+$838K |
| 4 |
Qualcomm
QCOM
|
+$632K |
| 5 |
Thermo Fisher Scientific
TMO
|
+$539K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.21% |
| 2 | Miscellaneous | 20.63% |
| 3 | Consumer Staples | 10.23% |
| 4 | Consumer Discretionary | 9.2% |
| 5 | Communication Services | 6.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Danaher
DHR
$153B
| $235K | 0.11% |
1,194
-1,740
| -59% | -$337K |
2023 Q4
6 quarters
|
|
77
Vanguard Total International Stock ETF
VXUS
$159B
| $226K | 0.1% |
+3,284
| New | +$213K |
2025 Q2
0 quarters
|
|
78
Boeing
BA
$148B
| $223K | 0.1% |
+1,066
| New | +$201K |
2025 Q2
0 quarters
|
|
79
TJX Companies
TJX
$153B
| $216K | 0.1% |
1,750
-250
| -13% | -$31.7K |
2023 Q4
6 quarters
|
|
80
Avantis Real Estate ETF
AVRE
$839M
| $22K | 0.01% |
500
| – | – |
2025 Q1
1 quarter
|
|
81
Vanguard Morningstar Value ETF
VTV
$188B
| $19K | 0.01% |
112
| – | – |
2025 Q1
1 quarter
|
|
82
Vanguard Morningstar Growth ETF
VUG
$235B
| $7K | ﹤0.01% |
108
| – | – |
2025 Q1
1 quarter
|
|
83
AbbVie
ABBV
$481B
| – | – |
-1,060
| Closed | -$222K | – |
|
84
Bristol-Myers Squibb
BMY
$122B
| – | – |
-5,436
| Closed | -$331K | – |
|
85
DuPont de Nemours
DD
$17.9B
| – | – |
-3,246
| Closed | -$304K | – |
|
86
Merck
MRK
$351B
| – | – |
-2,274
| Closed | -$204K | – |
|
87
Schwab US Large- Cap ETF
SCHX
$74.9B
| – | – |
-149
| Closed | -$3K | – |
|
|
88
Thermo Fisher Scientific
TMO
$241B
| – | – |
-1,085
| Closed | -$539K | – |
|
Similar funds
PP
QHA
WCM
FC
4A
MM
I
AWM
PFC Capital Group's Q2 2025 Portfolio in Review
As of Q2 2025, PFC Capital Group held 88 positions worth $216M, up 8.9% from $198M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
PFC Capital Group's Q2 2025 filing shows 2 new, 13 increased, 58 reduced and 6 closed positions. Its largest new stake was Vanguard Total International Stock ETF: 3,284 shares worth $226K. The largest sale was Microsoft, an estimated $1.34M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 39% a quarter earlier, followed by Miscellaneous and Consumer Staples.
- PFC Capital Group's largest Q2 2025 buy was Vanguard Total International Stock ETF: 3,284 shares worth $226K.
- PFC Capital Group added most to Vanguard S&P 500 ETF in Q2 2025, an estimated $2.17M increase.
- PFC Capital Group's biggest Q2 2025 reduction was Microsoft, cutting an estimated $1.34M.
- PFC Capital Group fully exited Thermo Fisher Scientific in Q2 2025, selling an estimated $539K.
- PFC Capital Group's ten largest holdings make up 55% of its $216M portfolio in Q2 2025.
- PFC Capital Group opened 2 new positions and closed 6 in Q2 2025.
- PFC Capital Group's portfolio value rose 8.9% quarter-over-quarter to $216M.
Based on PFC Capital Group's 13F filing for Q2 2025, filed 12 Aug 2025.